Coronary Artery Disease in Patients Undergoing Transvalvular Aortic Valve Implantation-Reference-Cited by-同舟云学术

Coronary Artery Disease in Patients Undergoing Transvalvular Aortic Valve Implantation

Published:2022-09-29 Issue: Volume:17 Page:
ISSN:1756-1485
Container-title:Interventional Cardiology: Reviews, Research, Resources
language:en
Short-container-title:Interv Cardiol

Author:

Lim Yinghao¹^ORCID,Anthony Tan Kent¹,Kuntjoro Ivandito¹,KF Hon Jimmy²^ORCID,Yip James¹,Tay Edgar¹^ORCID

Affiliation:

1. Department of Cardiology, National University Heart Centre, Singapore

2. Department of Cardiac, Thoracic, and Vascular Surgery, National University Heart Centre, Singapore

Abstract

Coronary artery disease (CAD) is common in patients with severe aortic stenosis. With the advent of transcatheter aortic valve implantation (TAVI) as a therapeutic option, management of CAD in such patients has undergone a revolution. Younger patients are now candidates for treatment, and have a greater life-time probability of requiring post-TAVI coronary access. Considerations include pre-procedural assessment and revascularisation, procedural planning to avoid coronary obstruction as well as optimisation of post-procedural coronary access. The authors review the challenges of managing CAD in TAVI patients, shed light on the evidence base, and provide guidance on how to optimise management.

Publisher

Radcliffe Media Media Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference89 articles.

1. Danielsen R, Aspelund T, Harris TB, Gudnason V. The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavik study. Int J Cardiol 2014;176:916–22. https://doi.org/10.1016/j.ijcard.2014.08.053; PMID: 25171970.

2. Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013;62:1002–12. https://doi.org/10.1016/j.jacc.2013.05.015; PMID: 23727214.

3. Hajar R. Risk factors for coronary artery disease: historical perspectives. Heart Views 2017;18:109–14. https://doi.org/10.4103/heartviews.heartviews_106_17; PMID: 29184622.

4. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143:e72–227. https://doi.org/10.1161/CIR.0000000000000923; PMID: 33332150.

5. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2019;40:87–165. https://doi.org/10.1093/eurheartj/ehy394; PMID: 30165437.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of implant projection in optimizing transcatheter aortic valve implantation;REC: interventional cardiology (English Edition);2024-08-14

2. Deep Learning Image Reconstruction for Transcatheter Aortic Valve Implantation Planning: Image Quality, Diagnostic Performance, Contrast volume and Radiation Dose Assessment;Academic Radiology;2024-06

3. Evaluation and management of coronary artery disease in patients undergoing transcatheter aortic valve implantation;Vessel Plus;2024-01-23

4. New Whole-Heart motion correction algorithm enables diagnostic CT of aortic valve and coronary arteries in systolic phase for transcatheter aortic valve implantation candidates;European Journal of Radiology;2023-11

5. Long-Term Prognosis and Predictors of Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Retrospective Analysis;Cureus;2023-08-31